secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alignment Healthcare, Inc. (ALHC)
CIK:        0001832466
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0000950170-23-048416
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alignment Healthcare grants performance-based RSUs to executives; CEO target 2.18M shares
--------------------------------------------------------------------------------

- CEO John Kao receives threshold 1,088,667, target 2,177,333, max 3,266,000 PSUs tied to 2024 performance.
- CFO Thomas Freeman and President Dawn Maroney each receive threshold 436,833, target 873,667, max 1,310,500 PSUs.
- PSU vesting: 50% on certification date (~Mar 2025), 50% on Dec 31, 2025, subject to continued service.
- Performance metrics weighted: Health Plan Revenue Growth 60%, MBR 20%, Adjusted EBITDA less CapEx 20%.
- Awards range 0% to 150% of target based on achievement of pre-set goals for 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832466/000095017023048416/0000950170-23-048416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832466/000095017023048416/alhc-20230914.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-048416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer